Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Headache Center of Southern California is a specialty headache and neurology care practice in Southern California focused on the diagnosis and treatment of migraine and other headache disorders. Available public information indicates it operates as a clinical care center rather than a drug-development biotech company, with services centered on comprehensive headache management, including preventive and acute treatment approaches delivered by headache-medicine specialists. The center has been publicly associated with neurologists including Andrew Blumenfeld and Jack Schim, and appears to have operated in connection with The Neurology Center of Southern California. It should be classified as a healthcare services organization, not a therapeutics developer, and no proprietary pharmaceutical pipeline was identified from public sources.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Headache Center of Southern California.